Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 16, 2023, titled "Zydus receives final approval from the USFDA for Lacosamide Tablets".
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 16, 2023, titled "Zydus receives final approval from the USFDA for Lacosamide Tablets".